Clinical relevance of BCL-2 overexpression in childhood acute lymphoblastic leukemia

Blood

Volumn 87, Issue 3, 1996, Pages 1140-1146

  Coustan Smith, Elaine ^b   Kitanaka, Akira ^b   Pui, Ching Hon ^b   McNinch, Lisa ^b   Evans, William E ^b   Raimondi, Susana C ^b   Behm, Frederick G ^b   Aricò, Maurizio ^b   Campana, Dario ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; CANCER RECURRENCE; CANCER RESISTANCE; CHILD; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; LYMPHOBLAST; MAJOR CLINICAL STUDY; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL;

EID: 0030067476     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.3.1140.bloodjournal8731140     Document Type: Article

References (52)

1. Vaux DL, Cory S, Adams JM: Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize preB cells. Nature 335:440, 1988
2. Hockenbery D, Nunez G, Milhman C. Schreiber RD, Korsmeyer SJ: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death Nature 348:334, 1990
3. Sentman CL, Shutter JR, Hockenbery D, Kanagawa O, Korsmeyer SJ: Bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67:879, 1991
4. Nunez G, London L, Hockenbery D, Alexander M, McKearn JP, Korsmeyer SJ: Deregulated bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines J Immunol 144:3602, 1990
5. Nunez G, Hockenbery D, McDonnell TJ, Sorensen CM, Korsmeyer SJ: Bcl-2 maintains B cell memory. Nature 353:71, 1991
6. Strasser A, Harris, AW, Cory S: Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 67:889, 1991
7. Miyashita T, Reed JC: BCL-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 81:151, 1993
8. Reed JC: Bcl-2: Prevention of apoptosis as a mechanism of drug resistance. Hematol Oncol Clin North Am 9:451, 1995
9. Lotem J, Sachs L: Control of sensitivity to induction of apoptosis in myeloid leukemic cells by differentiation and bcl-2 dependent and independent pathways. Cell Growth Differ 5:321, 1994
10. Reed JC, Kitada S, Takayama S, Miyashita T: Regulation of chemoresistance by the bcl-2 oncoprotein in non-Hodgkin's lymphoma and lymphocytic leukemia cell lines. Ann Oncol 5:61, 1994 (suppl 1)
11. Campos L, Rouault JP, Sabido O, Oriol P, Roubi N, Vasselon C, Archimbaud E, Magaud JP, Guyotat D: High expression of bcl2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood 81:3091, 1993
12. Porwit-MacDonald A, Ivory K, Wilkinson S, Wheatley K, Wong L, Janossy G: BCL-2 protein expression in normal human bone marrow precursors and in acute myelogenous leukemia. Leukemia 9:1191, 1995
13. Castle VP, Heidelberger KP, Bromberg J, Ou X, Dole M, Nunez G: Expression of the apoptosis-suppressing protein bcl-2 in neuroblastoma is associated with unfavorable histology and N-myc amplification. Am J Pathol 143:1543, 1993
14. McDonnell TJ, Troncoso P, Brisbay SM, Logothetis C, Ching LWK, Hsieh JT, Tu SM, Campbell ML: Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res 52:6940, 1992
15. Sierra A, Lloveras B, Castellsague X, Moreno L, Garcia-Ramirez M, Fabra A: Bcl-2 expression is associated with lymph node metastasis in human ductal breast carcinoma. Int J Cancer 60:54, 1995
16. Campana D, Coustan-Smith E, Manabe A, Buschle M, Raimondi SC, Behm FG, Ashmun R, Aricò M, Biondi A, Pui C-H: Prolonged survival of B-lineage acute lymphoblasic leukemia cells is accompanied by overexpression of BCL-2 protein. Blood 81:1025, 1993
17. Pezzella F, Tse AGD, Cordell JL, Pulford KAF, Gatter KC, Mason DY: Expression of the bcl-2 oncogene protein is not specific for the 14; 18 chromosomal translocation. Am J Pathol 137:225, 1990
18. Muirhead KA, Schmitt TC, Muirhead AR: Determination of linear fluorescence intensities from flow cytometric data accumulated with logarithmic amplifiers. Cytometry 3:251, 1983
19. Manabe A, Coustan-Smith E, Behm FG, Raimondi SC, Campana D: Bone marrow-derived stromal cells prevent apoptotic cell death in B-lineage acute lymphoblastic leukemia. Blood 79:2370, 1992
20. Manabe A, Murti KG, Coustan-Smith E, Kumagai M, Behm FG, Raimondi SC, Campana D: Adhesion-dependent survival of normal and leukemic human B lymphoblasts on bone marrow stromal cells. Blood 83:758, 1994
21. Manabe A, Coustan-Smith E, Kumagai M, Behm FG, Raimondi SC, Pui C-H, Campana D: Interleukin-4 induces programmed cell death (apoptosis) in cases of high risk acute lymphoblastic leukemia Blood 83:1731, 1994
22. Kumagai M, Coustan-Smith E, Murry DJ, Silvennoinen O, Murti KG, Evans WE, Malavasi F, Campana D: Ligation of CD38 suppresses human B lymphopoiesis. J Exp Med 181:1101, 1995
23. Campana D, Manabe A, Evans WE: Stroma-supported immunocytometric assay (SIA): A novel method for testing the sensitivity of acute lymphoblastic leukemia cells to cytotoxic drugs. Leukemia 7:482, 1993
24. DeLean A, Munson PJ, Rodbord D: Simultaneous analysis of families of sigmoid curves: Application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol 235:E97, 1978
25. Evans WE, Rodman J, Relling MV, Crom WR, Rivera GK, Crist WM, Pui C-H: Individualized dosages of chemotherapy as a strategy to improve response for acute lymphocytic leukemia. Semin Hematol 28:15, 1991
26. Pui CH, Crist WM, Look AT: Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia. Blood 76:1449, 1990
27. Tsujimoto Y, Cossman J, Jaffe E, Croce CM: Involvement of the bcl-2 gene in human follicular lymphoma. Science 228.1440, 1985
28. Reed JC, Cuddy M, Slabiak T, Croce CM, Nowell PC: Oncogenic potential of bcl-2 demonstrated by gene transfer. Nature 336:259, 1988
29. McDonnell TJ, Korsmeyer SJ: Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18). Nature 349:254, 1991
30. Korsmeyer SJ: BCL-2 initiates a new category of oncogenes: Regulators of cell death. Blood 80:879, 1992
31. Sawyers CL, Denny CT, Witte ON: Leukemia and disruption of normal hematopoiesis. Cell 64:337, 1991
32. Van Dongen JJM, Wolvers-Tettero ILM: Analysis of immunoglobulin and T cell receptor genes. Part II: Possibilities and limitations in the diagnosis and management of lymphoproliferative diseases and related disorders. Clin Chim Acta 198:93, 1991
33. Strasser A, Harris AW, Cory S: Eμ-bcl-2 transgene facilitates spontaneous transformation of early pre-B and immunoglobulin-secreting cells but not T cells. Oncogene 8:1, 1993
34. Merino R, Ding L, Veis DJ, Korsmeyer, SJ, Nunez G: Developmental regulation of the Bcl-2 protein and susceptibility to cell death in B lymphocytes. EMBO J 13:683, 1994
35. Evans CA, Owen-Lynch PJ, Whetton AD, Dive C: Activation of the Abelson tyrosine kinase activity is associated with suppression of apoptosis in hemopoietic cells. Cancer Res 53:1735, 1993
36. Gasparini G, Barbareschi M, Doglioni C, Dalla Palma P, Mauri FA, Boracchi P, Bevilacqua P, Caffo O, Morelli L, Verderio P, Pezzella F, Harris AL: Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer. Clin Cancer Res 1:189, 1995
37. Silvestrini R, Veneioni S, Daidone MG, Benini E, Boracchi P, Mezzetti M, Di Fronzo G, Rilke F, Veronesi U: The Bcl-2 protein: A prognostic indicator strongly related to p53 protein in lymph nodenegative breast cancer patients. J Natl Cancer Inst 86:499, 1994
38. Oltvai ZN, Milliman CL, Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609, 1993
39. Yin XM, Oltvai ZN, Korsmeyer SJ: BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature 369:321, 1994
40. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB: bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597, 1993
41. Kozopas KM, Yang T, Buchan HL, Zhou P, Craig RW: MCL-I, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL-2. Proc Natl Acad Sci USA 90:3515, 1993
42. Lin EY, Orlofsky A, Berger MS, Prystowsky MB: Characterization of A1, a novel hemopoietic-specific early-response gene with sequence similarity to bcl-2. J Immunol 151:1979, 1993
43. Takayama S, Sato T, Krajewski S, Kochel K, Irie S, Millan JA, Reed JC: Cloning and functional analysis of BAG-1: A novel BCL-2-binding protein with anti-cell death activity. Cell 80:279, 1995
44. L and Bcl-2, displaces Bax and promotes cell death. Cell 80:285, 1995
45. Farrow SN, White JHM, Martinou I, Raven T, Pun KT, Grinham CJ, Martinou JC, Brown R: Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K. Nature 374:731, 1995
46. Chittenden T, Harrington EA, O'Connor R, Flemington C, Lutz RJ, Evan GI, Guild BC: Induction of apoptosis by the bcl-2 homologue Bak. Nature 374:733, 1995
47. Kiefer MC, Brauer MJ, Powers VC, Wu JJ, Umansky SR, Tomei LD, Barr PJ: Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature 374:736, 1995
48. Piris MA, Pezzella F, Martinez-Montero JC, Orradre JL, Villuendas R, Sanchez-Beato M, Cuena R, Cruz MA, Martinez B, Garrido MC, Gatter K, Aiello A, Delia D, Giardini R, Rilke F: p53 and bcl-2 expression in high-grade B-cell lymphomas: Correlation with survival time. Br J Cancer 69:337, 1994
49. Pezzella F, Turley H, Kuzu I, Tungekar MF, Dunnill MS, Pierce CB, Harris A, Gatter KC, Mason DY: Bcl-2 protein expression in non-small-cell lung carcinoma. N Engl J Med 329:690, 1993
50. Joensuu H, Pylkkanen L, Toikkanen S: Bcl-2 protein expression and long-term survival in breast cancer. Am J Pathol 145:1191, 1994
51. Gala JL, Vermylen C, Cornu G, Ferrant A, Michaux JL, Philippe M, Martiat P: High expression of bcl-2 is the rule in acute lymphoblastic leukemia, except in Burkitt subtype at presentation, and is not correlated with the prognosis. Ann Hematol 69:17, 1994
52. Griffiths SD, Goodhead DT, Marsden SJ, Wright EG, Krajewski S, Reed JC, Korsmeyer SJ, Greaves M: Interleukin 7-dependent B lymphocyte precursor cells are ultrasensitive to apoptosis. J Exp Med 179:1789, 1994